<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01405092</url>
  </required_header>
  <id_info>
    <org_study_id>#09-097</org_study_id>
    <nct_id>NCT01405092</nct_id>
  </id_info>
  <brief_title>Continuous Versus Conventional Volume Management During CRRT (Continuous Renal Replacement Therapy)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dallas VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dallas VA Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of on-line blood volume monitoring during continuous renal replacement therapy can
      improve volume management in acute kidney injury patients requiring renal replacement
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>compare number of hypotensive events in treatment versus control arms</measure>
    <time_frame>24 hour for each arm</time_frame>
    <description>compare the number of hypotensive events during use of crit-line monitor over 24 hour period versus during control 24 hour period</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Continuous Renal Replacement Therapy</condition>
  <arm_group>
    <arm_group_label>Standard volume management</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patients on this arm will receive usual care volume management during continuous renal replacement therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>continuous volume management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>use of Critline, Hemametrics USA, in conjunction with continuous renal replacment therapy to determine volume removal</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>use of continuous renal replacement machine for renal replacement</intervention_name>
    <description>usual care with volume removal during continuous renal replacement therapy</description>
    <arm_group_label>Standard volume management</arm_group_label>
    <arm_group_label>continuous volume management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>use of blood volume monitoring device in conjunction with machine used for continuous renal replacement to assess and determine volume removal</intervention_name>
    <description>blood volume monitoring device, Critline, Hemametric, USA, will be used in conjunction with continuous renal replacement to determine rate of volume removal</description>
    <arm_group_label>continuous volume management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with kidney injury requiring continuous renal replacement therapy and volume
             removal

        Exclusion Criteria:

          -  unable to provide or obtain patient consent

          -  not expected to survive 48 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dallas VA Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2011</study_first_submitted>
  <study_first_submitted_qc>July 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2011</study_first_posted>
  <last_update_submitted>August 7, 2012</last_update_submitted>
  <last_update_submitted_qc>August 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dallas VA Medical Center</investigator_affiliation>
    <investigator_full_name>Devasmita C. Dev MD</investigator_full_name>
    <investigator_title>Director of In-center and Home Dialysis</investigator_title>
  </responsible_party>
  <keyword>volume</keyword>
  <keyword>acute kidney injury</keyword>
  <keyword>continuous renal replacement</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

